Data

Stepped care approach for medial tibiofemoral osteoarthritis (STREAMLINE) dataset

THE UNIVERSITY OF SYDNEY

Dataset description

The full dataset includes the data of 170 participants including demographics, clinical, characteristics and outcomes at baseline, 20 and 32 weeks.
Click to explore relationships graph

Subjects

Rheumatology |

Source Study

Trial acronym

Not available

Trial ID

ACTRN12615000227594

Purpose

Treatment

Phase

Not Applicable

Funding

Government body,National Health and Medical Research Council

Scientific enquiries

Prof David Hunter

Brief Summary

The current approach in the management of osteoarthritis is primarily palliative and is aimed at alleviating symptoms. By contrast, current literature is increasingly advocating the identification of prognostic indicators, such as muscle weakness, mal­alignment and depression that may be amenable to treatment. That is, to provide a more holistic approach to the management of osteoarthritis as well as to facilitate an improvement in an individual’s joint pain and function rather than treating eve ....
Read more

Key Inclusion Criteria

- Age 50 years and over - BMI greater than or equal to 28 - VAS pain greater than or equal to 4 out of 10 - PASS scores greater than 32.0mm for pain, 32.0mm for global assessment score and 31mm for the WOMAC questions - Knee pain and stiffness in the past 30 days - Radiographic evidence of a definite osteophyte - Radiographic evidence of disease in the medial tibiofemoral compartment -Minimum grade 1 medial tibiofemoral joint space narrowing based on the Osteoarthritis Research Society Internati ....
Read more

Key Exclusion Criteria

- Clinical evidence of predominant patellofemoral disease - Clinical evidence of lateral tibiofemoral disease - Any other knee pathology that is likely to be contributing to their knee pain (e.g. pes anserine bursitis, referred pain from back or hip, secondary osteoarthritis (from inflammatory rheumatic diseases such as rheumatoid arthritis or gout)

Can healthy volunteers participate?

No

 

Population

Sample Size    171

Min. age    50 Years

Max. age    No limit

Sex    Both males and females

Condition category    Depression , Medial tibiofemoral Osteoarthritis , Obesity

Condition code    Diet and Nutrition , Mental Health , Musculoskeletal

Intervention

Intervention code Behaviour , Treatment: Devices , Treatment: Other

Arm 1 – 18 week diet and exercise as prescribed by the Healthy Weight for Life program (healthyweightforlife.com.au) The Healthy Weight for Life is a specialised arthritis chronic disease management program that targets multiple modifiable OA risk factors by carefully integrating: a. Weight loss and improved nutrition - a stepped intervention designed to achieve a progressive and practical implementation of normal, healthy portion-controlled eating and drinking, through education and resources. ....
Read more

Comparison

Control group Active

The Control Group will be provided with a selection of education pamphlets. These fact sheets will be taken from MyJointPain.org.au, a website which was launched in partnership with Arthritis Australia and is a source of reliable information for individuals with OA. It can inform patients if they have the disease and how to manage it. Similarly, it provides users with a collection of OA healthcare services in order to allow patients to determine who is best suited to manage their disease.

Outcomes

Outcome: Disease Remission to be measured by the Patient Acceptable Symptom State Score (PASS)
Timepoint: At Baseline and at 20 and 32 weeks after intervention commencement

Study Protocol: Not Available
Data Dictionary: Not Available

Will individual participant data (IPD) for this trial be available?

yes

What data in particular will be shared?

We will share the data of 170 consented participants including demographics, clinical characteristics and outcome measures at baseline, weeks 20 and 32.

When will data be available?

After a research proposal from a secondary researcher receives a waiver of consent from the ethics committee, data will be available for an indefinite time.

Available to whom?

Researchers interested in using IPD for future studies.

Available for what types of analyses?

Any type of analyses.

Source study information is derived from the Australian New Zealand Clinical Trials Registry (ANZCTR). For more information on the ANZCTR, please see anzctr.org.au